Business Context and Reporting Period
Gulf Resources, Inc. (GURE) filed a Form 8-K on December 29, 2025, to report the closing of a significant equity transaction. The Company is incorporated in Nevada with principal executive offices in Shouguang City, Shandong Province, China.
Key Financial Metrics
This filing does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Instead, it incorporates by reference the Company's financial statements for the year ended December 31, 2024, and the nine months ended September 30, 2025. Unaudited pro forma condensed combined financial information for the same periods is provided in Exhibit 99.1.
Material Changes
- Transaction Closing: On December 22, 2025, the Company completed the sale of 100% of the equity interest in Shouguang Yuxin Chemical Industry Co., Limited (the "Target Company") to Shandong Rongyuan Pharmaceutical Co., Ltd. (the "Purchaser").
- Regulatory Approval: The relevant governmental body (AMR) completed the industrial and commercial change registration on December 22, 2025, confirming the Purchaser as the sole shareholder of the Target Company.
- Agreement Details: The transaction was executed pursuant to a Stock Purchase Agreement (SPA) dated December 10, 2025, between the Seller (Shouguang City Haoyuan Chemical Company Limited, an indirect wholly-owned subsidiary of Gulf Resources) and the Purchaser.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding management's intentions and expectations, which are subject to risks and uncertainties. These risks are detailed in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, and its Quarterly Report on Form 10-Q for the quarter ended September 30, 2025. The Company disclaims any obligation to update these statements except as required by law. No specific financial guidance or outlook is provided in this document.
Investor Verification Checklist
- Review Exhibit 99.1 for the unaudited pro forma financial statements to understand the impact of the divestiture on the Company's financial position.
- Examine the referenced Form 10-K (filed April 11, 2025) and Form 10-Q (filed November 19, 2025) for historical financial data and risk factors.
- Verify the terms of the December 10, 2025, Stock Purchase Agreement to understand the consideration received for the Target Company.
- Confirm the current status of the Company's remaining operations following the sale of the Target Company.